EDACS — Emergency Department Assessment of Chest Pain
Score for low-risk chest pain in the ED, intended for use with 2h serial troponin to identify patients safe for early discharge. Validated with high-sensitivity troponin.
Score interpretation
Low risk only if the ECG shows no new ischaemia and the 0 h and 2 h troponins are both negative (EDACS-ADP).
→ If the ECG and both troponins are negative: suitable for early discharge with outpatient follow-up.
Not eligible for the EDACS accelerated diagnostic pathway.
→ Usual care: further observation, delayed troponin and cardiology review per local ACS pathway.
Interpretation bands for the EDACS. Apply clinical judgement and local guidance.
References
- Than M, Flaws D, Sanders S, et al. Development and validation of the Emergency Department Assessment of Chest pain Score and 2 h accelerated diagnostic protocol. Emerg Med Australas. 2014;26(1):34–44.
Related
Curated clinical cross-links plus same-class fallbacks.
- Labetalol (IV — Hypertensive Emergency) · Combined Alpha-1 and Beta-Adrenergic Blocker
- Labetalol (IV — Hypertensive Emergency) · Combined alpha and beta blocker
- Adrenaline (Anaphylaxis Protocol) · Auto-injector / IM adrenaline for anaphylaxis
- Tenecteplase · Cardiovascular Emergency
- Tirofiban · Cardiovascular Emergency
- Terlipressin · Gastrointestinal Emergency
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
The EDACS is covered in detail — with RCEM/NICE evidence base, indications and pitfalls — in the following exam-focused pathways on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.